Controversies in intensive care medicine:
Gespeichert in:
Weitere Verfasser: | , |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Berlin, [Germany]
Medizinisch Wissenschaftliche Verlagsgesellschaft
2008
|
Schlagworte: | |
Online-Zugang: | FAW01 FAW02 |
Beschreibung: | Description based on online resource; title from PDF title page (ebrary, viewed March 4, 2015) |
Beschreibung: | 1 online resource (534 pages) illustrations |
ISBN: | 9783954661916 3954661918 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV043784461 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 160920s2008 |||| o||u| ||||||eng d | ||
020 | |a 9783954661916 |9 978-3-95466-191-6 | ||
020 | |a 3954661918 |9 3-95466-191-8 | ||
035 | |a (ZDB-4-EBA)ocn905914869 | ||
035 | |a (OCoLC)905914869 | ||
035 | |a (DE-599)BVBBV043784461 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
049 | |a DE-1046 |a DE-1047 | ||
082 | 0 | |a 616.028 |2 23 | |
245 | 1 | 0 | |a Controversies in intensive care medicine |c Ralf Kuhlen [and three others] (eds.) ; European Society of Intensive Care Medicine ; with contributions from, MG Abate [and one hundred thirteen others] |
264 | 1 | |a Berlin, [Germany] |b Medizinisch Wissenschaftliche Verlagsgesellschaft |c 2008 | |
264 | 4 | |c © 2008 | |
300 | |a 1 online resource (534 pages) |b illustrations | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
500 | |a Description based on online resource; title from PDF title page (ebrary, viewed March 4, 2015) | ||
505 | 8 | |a Cover; Impressum; Preface; Content; A. Acute respiratory failure; Noninvasive ventilation in hypoxemic respiratory insufficiency; Weaning: Protocols vs. clinically driven; Pressure-volume curves: Useful in clinical practice; Replacing or restricting fluids: Timing, dosing and choosing the type of fluid in patients with or at risk for ALI/ARDS; Spontaneous versus mechanical ventilation; The role of tracheostomy in ventilatory care; B. Acute circulatory failure; Controversies in cardiac output monitoring; Crystalloids versus colloids versus albumin: Where do we stand? | |
505 | 8 | |a ScvO2 as a marker for resuscitation in intensive careCalcium sensitisers versus dobutamine in acute heart failure ; Macro vs. micro targets for haemodynamic support; Right heart failure determines outcome; Do we really need SPV/PPV to detect low filling status? ; Vasopressors in the patient with shock; Controversies in coronary care; C. Acute kidney injury; Renal replacement therapies: When, how, and how much?; Anticoagulation for renal replacement therapy: Heparin or citrate; D. Sepsis and infection; Diagnosis of Ventilator-associated Pneumonia | |
505 | 8 | |a Antibiotic combination vs. monotherapy in critically ill patients with pneumoniaDo antibiotic protocols impact on resistance?; The activated protein C controversy; Corticosteroids in septic shock; Controversies in goal-directed therapy: Venous saturations and lactate; Starting and stopping antibiotic therapy; MRSA control; E. Neuro-intensive care; Does ICP monitoring improve outcome after traumatic brain injury?; What care should be provided for poor grade subarachnoid haemorrhage patients?; Induced hypothermia to treat neurological injuries | |
505 | 8 | |a Can we increase/lengthen the time window from 3-6 hours for thrombolysis after stroke?Neuroprotective ventilation; F. Acute bleeding; Monitoring the coagulation; Management of refractory bleeding; G. Organisational issues; Optimisation of patient process and workflow; Reducing the number of adverse events in intensive care units; Early discharge from the ICU is safe; Implementation of surveillance networks; Should hospitals have a medical emergency team?; E-learning; High acuity nurse patient ratio -- is it cost-effective?; The role of specialist (neurological critical care) units | |
505 | 8 | |a Building and using outcome prediction models: Should we be lumpers or splitters?Specialty of intensive care: Primary specialty vs. supraspecialty; H. Surgical intensive care and trauma; Fast track after cardiac surgery; Fluid: Replace or restrict?; Bedside surgery in the ICU; I. Adjunctive issues; Technology assessment and procurement: 'Monitoring the monitor'; Controversies in intensive care sedation: Continuous infusions in awake patients and end-of-life sedation; Tight glucose control: Should we target normoglycemia or an intermediate level?; Goals for nutrition support in the ICU. | |
505 | 8 | |a In recent years, many clinical interventions in intensive care medicine have been based on clear scientific evidence. However, at least as many clinical interventions still remain the subject of controversy, either due to a lack of rigorous data or due to the existence of conflicting data. In this book, these controversies are discussed by experts of international renown in their respective fields | |
650 | 4 | |a Intensive care units | |
650 | 4 | |a intensive therapy | |
650 | 7 | |a HEALTH & FITNESS / Diseases / General |2 bisacsh | |
650 | 7 | |a MEDICAL / Clinical Medicine |2 bisacsh | |
650 | 7 | |a MEDICAL / Diseases |2 bisacsh | |
650 | 7 | |a MEDICAL / Evidence-Based Medicine |2 bisacsh | |
650 | 7 | |a MEDICAL / Internal Medicine |2 bisacsh | |
650 | 4 | |a Evidenz-basierte Medizin | |
650 | 4 | |a Innere Medizin | |
650 | 4 | |a Medizin | |
650 | 4 | |a Critical care medicine | |
650 | 0 | 7 | |a Intensivtherapie |0 (DE-588)4027258-8 |2 gnd |9 rswk-swf |
655 | 7 | |8 1\p |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
655 | 7 | |8 2\p |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
689 | 0 | 0 | |a Intensivtherapie |0 (DE-588)4027258-8 |D s |
689 | 0 | |8 3\p |5 DE-604 | |
700 | 1 | |a Kuhlen, R. |4 edt | |
700 | 1 | |a Abate, M. G. |4 ctb | |
710 | 2 | |a European Society of Intensive Care Medicine |e Sonstige |4 oth | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |a Moreno, Rui P |t . Controversies in Intensive Care Medicine |
912 | |a ZDB-4-EBA | ||
999 | |a oai:aleph.bib-bvb.de:BVB01-029195521 | ||
883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
883 | 1 | |8 3\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1044601 |l FAW01 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1044601 |l FAW02 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext |
Datensatz im Suchindex
_version_ | 1804176617235283968 |
---|---|
any_adam_object | |
author2 | Kuhlen, R. Abate, M. G. |
author2_role | edt ctb |
author2_variant | r k rk m g a mg mga |
author_facet | Kuhlen, R. Abate, M. G. |
building | Verbundindex |
bvnumber | BV043784461 |
collection | ZDB-4-EBA |
contents | Cover; Impressum; Preface; Content; A. Acute respiratory failure; Noninvasive ventilation in hypoxemic respiratory insufficiency; Weaning: Protocols vs. clinically driven; Pressure-volume curves: Useful in clinical practice; Replacing or restricting fluids: Timing, dosing and choosing the type of fluid in patients with or at risk for ALI/ARDS; Spontaneous versus mechanical ventilation; The role of tracheostomy in ventilatory care; B. Acute circulatory failure; Controversies in cardiac output monitoring; Crystalloids versus colloids versus albumin: Where do we stand? ScvO2 as a marker for resuscitation in intensive careCalcium sensitisers versus dobutamine in acute heart failure ; Macro vs. micro targets for haemodynamic support; Right heart failure determines outcome; Do we really need SPV/PPV to detect low filling status? ; Vasopressors in the patient with shock; Controversies in coronary care; C. Acute kidney injury; Renal replacement therapies: When, how, and how much?; Anticoagulation for renal replacement therapy: Heparin or citrate; D. Sepsis and infection; Diagnosis of Ventilator-associated Pneumonia Antibiotic combination vs. monotherapy in critically ill patients with pneumoniaDo antibiotic protocols impact on resistance?; The activated protein C controversy; Corticosteroids in septic shock; Controversies in goal-directed therapy: Venous saturations and lactate; Starting and stopping antibiotic therapy; MRSA control; E. Neuro-intensive care; Does ICP monitoring improve outcome after traumatic brain injury?; What care should be provided for poor grade subarachnoid haemorrhage patients?; Induced hypothermia to treat neurological injuries Can we increase/lengthen the time window from 3-6 hours for thrombolysis after stroke?Neuroprotective ventilation; F. Acute bleeding; Monitoring the coagulation; Management of refractory bleeding; G. Organisational issues; Optimisation of patient process and workflow; Reducing the number of adverse events in intensive care units; Early discharge from the ICU is safe; Implementation of surveillance networks; Should hospitals have a medical emergency team?; E-learning; High acuity nurse patient ratio -- is it cost-effective?; The role of specialist (neurological critical care) units Building and using outcome prediction models: Should we be lumpers or splitters?Specialty of intensive care: Primary specialty vs. supraspecialty; H. Surgical intensive care and trauma; Fast track after cardiac surgery; Fluid: Replace or restrict?; Bedside surgery in the ICU; I. Adjunctive issues; Technology assessment and procurement: 'Monitoring the monitor'; Controversies in intensive care sedation: Continuous infusions in awake patients and end-of-life sedation; Tight glucose control: Should we target normoglycemia or an intermediate level?; Goals for nutrition support in the ICU. In recent years, many clinical interventions in intensive care medicine have been based on clear scientific evidence. However, at least as many clinical interventions still remain the subject of controversy, either due to a lack of rigorous data or due to the existence of conflicting data. In this book, these controversies are discussed by experts of international renown in their respective fields |
ctrlnum | (ZDB-4-EBA)ocn905914869 (OCoLC)905914869 (DE-599)BVBBV043784461 |
dewey-full | 616.028 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.028 |
dewey-search | 616.028 |
dewey-sort | 3616.028 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>06092nmm a2200685zc 4500</leader><controlfield tag="001">BV043784461</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">160920s2008 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783954661916</subfield><subfield code="9">978-3-95466-191-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3954661918</subfield><subfield code="9">3-95466-191-8</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-4-EBA)ocn905914869</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)905914869</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043784461</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.028</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Controversies in intensive care medicine</subfield><subfield code="c">Ralf Kuhlen [and three others] (eds.) ; European Society of Intensive Care Medicine ; with contributions from, MG Abate [and one hundred thirteen others]</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin, [Germany]</subfield><subfield code="b">Medizinisch Wissenschaftliche Verlagsgesellschaft</subfield><subfield code="c">2008</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">© 2008</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (534 pages)</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Description based on online resource; title from PDF title page (ebrary, viewed March 4, 2015)</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Cover; Impressum; Preface; Content; A. Acute respiratory failure; Noninvasive ventilation in hypoxemic respiratory insufficiency; Weaning: Protocols vs. clinically driven; Pressure-volume curves: Useful in clinical practice; Replacing or restricting fluids: Timing, dosing and choosing the type of fluid in patients with or at risk for ALI/ARDS; Spontaneous versus mechanical ventilation; The role of tracheostomy in ventilatory care; B. Acute circulatory failure; Controversies in cardiac output monitoring; Crystalloids versus colloids versus albumin: Where do we stand?</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">ScvO2 as a marker for resuscitation in intensive careCalcium sensitisers versus dobutamine in acute heart failure ; Macro vs. micro targets for haemodynamic support; Right heart failure determines outcome; Do we really need SPV/PPV to detect low filling status? ; Vasopressors in the patient with shock; Controversies in coronary care; C. Acute kidney injury; Renal replacement therapies: When, how, and how much?; Anticoagulation for renal replacement therapy: Heparin or citrate; D. Sepsis and infection; Diagnosis of Ventilator-associated Pneumonia</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Antibiotic combination vs. monotherapy in critically ill patients with pneumoniaDo antibiotic protocols impact on resistance?; The activated protein C controversy; Corticosteroids in septic shock; Controversies in goal-directed therapy: Venous saturations and lactate; Starting and stopping antibiotic therapy; MRSA control; E. Neuro-intensive care; Does ICP monitoring improve outcome after traumatic brain injury?; What care should be provided for poor grade subarachnoid haemorrhage patients?; Induced hypothermia to treat neurological injuries</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Can we increase/lengthen the time window from 3-6 hours for thrombolysis after stroke?Neuroprotective ventilation; F. Acute bleeding; Monitoring the coagulation; Management of refractory bleeding; G. Organisational issues; Optimisation of patient process and workflow; Reducing the number of adverse events in intensive care units; Early discharge from the ICU is safe; Implementation of surveillance networks; Should hospitals have a medical emergency team?; E-learning; High acuity nurse patient ratio -- is it cost-effective?; The role of specialist (neurological critical care) units</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Building and using outcome prediction models: Should we be lumpers or splitters?Specialty of intensive care: Primary specialty vs. supraspecialty; H. Surgical intensive care and trauma; Fast track after cardiac surgery; Fluid: Replace or restrict?; Bedside surgery in the ICU; I. Adjunctive issues; Technology assessment and procurement: 'Monitoring the monitor'; Controversies in intensive care sedation: Continuous infusions in awake patients and end-of-life sedation; Tight glucose control: Should we target normoglycemia or an intermediate level?; Goals for nutrition support in the ICU.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">In recent years, many clinical interventions in intensive care medicine have been based on clear scientific evidence. However, at least as many clinical interventions still remain the subject of controversy, either due to a lack of rigorous data or due to the existence of conflicting data. In this book, these controversies are discussed by experts of international renown in their respective fields</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Intensive care units</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">intensive therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS / Diseases / General</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Clinical Medicine</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Diseases</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Evidence-Based Medicine</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Internal Medicine</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Evidenz-basierte Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Innere Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Critical care medicine</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Intensivtherapie</subfield><subfield code="0">(DE-588)4027258-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">1\p</subfield><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">2\p</subfield><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Intensivtherapie</subfield><subfield code="0">(DE-588)4027258-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">3\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kuhlen, R.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Abate, M. G.</subfield><subfield code="4">ctb</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">European Society of Intensive Care Medicine</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="a">Moreno, Rui P</subfield><subfield code="t">. Controversies in Intensive Care Medicine</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029195521</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1044601</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1044601</subfield><subfield code="l">FAW02</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
genre | 1\p (DE-588)4143413-4 Aufsatzsammlung gnd-content 2\p (DE-588)1071861417 Konferenzschrift gnd-content |
genre_facet | Aufsatzsammlung Konferenzschrift |
id | DE-604.BV043784461 |
illustrated | Illustrated |
indexdate | 2024-07-10T07:35:02Z |
institution | BVB |
isbn | 9783954661916 3954661918 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029195521 |
oclc_num | 905914869 |
open_access_boolean | |
owner | DE-1046 DE-1047 |
owner_facet | DE-1046 DE-1047 |
physical | 1 online resource (534 pages) illustrations |
psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
publishDate | 2008 |
publishDateSearch | 2008 |
publishDateSort | 2008 |
publisher | Medizinisch Wissenschaftliche Verlagsgesellschaft |
record_format | marc |
spelling | Controversies in intensive care medicine Ralf Kuhlen [and three others] (eds.) ; European Society of Intensive Care Medicine ; with contributions from, MG Abate [and one hundred thirteen others] Berlin, [Germany] Medizinisch Wissenschaftliche Verlagsgesellschaft 2008 © 2008 1 online resource (534 pages) illustrations txt rdacontent c rdamedia cr rdacarrier Description based on online resource; title from PDF title page (ebrary, viewed March 4, 2015) Cover; Impressum; Preface; Content; A. Acute respiratory failure; Noninvasive ventilation in hypoxemic respiratory insufficiency; Weaning: Protocols vs. clinically driven; Pressure-volume curves: Useful in clinical practice; Replacing or restricting fluids: Timing, dosing and choosing the type of fluid in patients with or at risk for ALI/ARDS; Spontaneous versus mechanical ventilation; The role of tracheostomy in ventilatory care; B. Acute circulatory failure; Controversies in cardiac output monitoring; Crystalloids versus colloids versus albumin: Where do we stand? ScvO2 as a marker for resuscitation in intensive careCalcium sensitisers versus dobutamine in acute heart failure ; Macro vs. micro targets for haemodynamic support; Right heart failure determines outcome; Do we really need SPV/PPV to detect low filling status? ; Vasopressors in the patient with shock; Controversies in coronary care; C. Acute kidney injury; Renal replacement therapies: When, how, and how much?; Anticoagulation for renal replacement therapy: Heparin or citrate; D. Sepsis and infection; Diagnosis of Ventilator-associated Pneumonia Antibiotic combination vs. monotherapy in critically ill patients with pneumoniaDo antibiotic protocols impact on resistance?; The activated protein C controversy; Corticosteroids in septic shock; Controversies in goal-directed therapy: Venous saturations and lactate; Starting and stopping antibiotic therapy; MRSA control; E. Neuro-intensive care; Does ICP monitoring improve outcome after traumatic brain injury?; What care should be provided for poor grade subarachnoid haemorrhage patients?; Induced hypothermia to treat neurological injuries Can we increase/lengthen the time window from 3-6 hours for thrombolysis after stroke?Neuroprotective ventilation; F. Acute bleeding; Monitoring the coagulation; Management of refractory bleeding; G. Organisational issues; Optimisation of patient process and workflow; Reducing the number of adverse events in intensive care units; Early discharge from the ICU is safe; Implementation of surveillance networks; Should hospitals have a medical emergency team?; E-learning; High acuity nurse patient ratio -- is it cost-effective?; The role of specialist (neurological critical care) units Building and using outcome prediction models: Should we be lumpers or splitters?Specialty of intensive care: Primary specialty vs. supraspecialty; H. Surgical intensive care and trauma; Fast track after cardiac surgery; Fluid: Replace or restrict?; Bedside surgery in the ICU; I. Adjunctive issues; Technology assessment and procurement: 'Monitoring the monitor'; Controversies in intensive care sedation: Continuous infusions in awake patients and end-of-life sedation; Tight glucose control: Should we target normoglycemia or an intermediate level?; Goals for nutrition support in the ICU. In recent years, many clinical interventions in intensive care medicine have been based on clear scientific evidence. However, at least as many clinical interventions still remain the subject of controversy, either due to a lack of rigorous data or due to the existence of conflicting data. In this book, these controversies are discussed by experts of international renown in their respective fields Intensive care units intensive therapy HEALTH & FITNESS / Diseases / General bisacsh MEDICAL / Clinical Medicine bisacsh MEDICAL / Diseases bisacsh MEDICAL / Evidence-Based Medicine bisacsh MEDICAL / Internal Medicine bisacsh Evidenz-basierte Medizin Innere Medizin Medizin Critical care medicine Intensivtherapie (DE-588)4027258-8 gnd rswk-swf 1\p (DE-588)4143413-4 Aufsatzsammlung gnd-content 2\p (DE-588)1071861417 Konferenzschrift gnd-content Intensivtherapie (DE-588)4027258-8 s 3\p DE-604 Kuhlen, R. edt Abate, M. G. ctb European Society of Intensive Care Medicine Sonstige oth Erscheint auch als Druck-Ausgabe Moreno, Rui P . Controversies in Intensive Care Medicine 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 3\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
spellingShingle | Controversies in intensive care medicine Cover; Impressum; Preface; Content; A. Acute respiratory failure; Noninvasive ventilation in hypoxemic respiratory insufficiency; Weaning: Protocols vs. clinically driven; Pressure-volume curves: Useful in clinical practice; Replacing or restricting fluids: Timing, dosing and choosing the type of fluid in patients with or at risk for ALI/ARDS; Spontaneous versus mechanical ventilation; The role of tracheostomy in ventilatory care; B. Acute circulatory failure; Controversies in cardiac output monitoring; Crystalloids versus colloids versus albumin: Where do we stand? ScvO2 as a marker for resuscitation in intensive careCalcium sensitisers versus dobutamine in acute heart failure ; Macro vs. micro targets for haemodynamic support; Right heart failure determines outcome; Do we really need SPV/PPV to detect low filling status? ; Vasopressors in the patient with shock; Controversies in coronary care; C. Acute kidney injury; Renal replacement therapies: When, how, and how much?; Anticoagulation for renal replacement therapy: Heparin or citrate; D. Sepsis and infection; Diagnosis of Ventilator-associated Pneumonia Antibiotic combination vs. monotherapy in critically ill patients with pneumoniaDo antibiotic protocols impact on resistance?; The activated protein C controversy; Corticosteroids in septic shock; Controversies in goal-directed therapy: Venous saturations and lactate; Starting and stopping antibiotic therapy; MRSA control; E. Neuro-intensive care; Does ICP monitoring improve outcome after traumatic brain injury?; What care should be provided for poor grade subarachnoid haemorrhage patients?; Induced hypothermia to treat neurological injuries Can we increase/lengthen the time window from 3-6 hours for thrombolysis after stroke?Neuroprotective ventilation; F. Acute bleeding; Monitoring the coagulation; Management of refractory bleeding; G. Organisational issues; Optimisation of patient process and workflow; Reducing the number of adverse events in intensive care units; Early discharge from the ICU is safe; Implementation of surveillance networks; Should hospitals have a medical emergency team?; E-learning; High acuity nurse patient ratio -- is it cost-effective?; The role of specialist (neurological critical care) units Building and using outcome prediction models: Should we be lumpers or splitters?Specialty of intensive care: Primary specialty vs. supraspecialty; H. Surgical intensive care and trauma; Fast track after cardiac surgery; Fluid: Replace or restrict?; Bedside surgery in the ICU; I. Adjunctive issues; Technology assessment and procurement: 'Monitoring the monitor'; Controversies in intensive care sedation: Continuous infusions in awake patients and end-of-life sedation; Tight glucose control: Should we target normoglycemia or an intermediate level?; Goals for nutrition support in the ICU. In recent years, many clinical interventions in intensive care medicine have been based on clear scientific evidence. However, at least as many clinical interventions still remain the subject of controversy, either due to a lack of rigorous data or due to the existence of conflicting data. In this book, these controversies are discussed by experts of international renown in their respective fields Intensive care units intensive therapy HEALTH & FITNESS / Diseases / General bisacsh MEDICAL / Clinical Medicine bisacsh MEDICAL / Diseases bisacsh MEDICAL / Evidence-Based Medicine bisacsh MEDICAL / Internal Medicine bisacsh Evidenz-basierte Medizin Innere Medizin Medizin Critical care medicine Intensivtherapie (DE-588)4027258-8 gnd |
subject_GND | (DE-588)4027258-8 (DE-588)4143413-4 (DE-588)1071861417 |
title | Controversies in intensive care medicine |
title_auth | Controversies in intensive care medicine |
title_exact_search | Controversies in intensive care medicine |
title_full | Controversies in intensive care medicine Ralf Kuhlen [and three others] (eds.) ; European Society of Intensive Care Medicine ; with contributions from, MG Abate [and one hundred thirteen others] |
title_fullStr | Controversies in intensive care medicine Ralf Kuhlen [and three others] (eds.) ; European Society of Intensive Care Medicine ; with contributions from, MG Abate [and one hundred thirteen others] |
title_full_unstemmed | Controversies in intensive care medicine Ralf Kuhlen [and three others] (eds.) ; European Society of Intensive Care Medicine ; with contributions from, MG Abate [and one hundred thirteen others] |
title_short | Controversies in intensive care medicine |
title_sort | controversies in intensive care medicine |
topic | Intensive care units intensive therapy HEALTH & FITNESS / Diseases / General bisacsh MEDICAL / Clinical Medicine bisacsh MEDICAL / Diseases bisacsh MEDICAL / Evidence-Based Medicine bisacsh MEDICAL / Internal Medicine bisacsh Evidenz-basierte Medizin Innere Medizin Medizin Critical care medicine Intensivtherapie (DE-588)4027258-8 gnd |
topic_facet | Intensive care units intensive therapy HEALTH & FITNESS / Diseases / General MEDICAL / Clinical Medicine MEDICAL / Diseases MEDICAL / Evidence-Based Medicine MEDICAL / Internal Medicine Evidenz-basierte Medizin Innere Medizin Medizin Critical care medicine Intensivtherapie Aufsatzsammlung Konferenzschrift |
work_keys_str_mv | AT kuhlenr controversiesinintensivecaremedicine AT abatemg controversiesinintensivecaremedicine AT europeansocietyofintensivecaremedicine controversiesinintensivecaremedicine |